NHS restricts use of puberty blockers for minors
The NHS announced Friday that it will only commission puberty-suppressing hormones as part of clinical research, effectively restricting the use of puberty-blocking drugs for gender transition outside of clinical trials.
The NHS announced Friday that it will only commission puberty-suppressing hormones as part of clinical research, effectively restricting the use of puberty-blocking drugs for gender transition outside of clinical trials.
